Single Dose of Vaccine Reduced Infection Chances by 65%, Finds New UK Study
3 years, 8 months ago

Single Dose of Vaccine Reduced Infection Chances by 65%, Finds New UK Study

News 18  

A single dose of either the Oxford AstraZeneca or Pfizer BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65 per cent, according to a new UK study. The researchers analysed Covid-19 test results from more than 3,50,000 people in the UK between December 2020 and April 2021 and found that 21 days after a first jab the time it takes the immune system to mount a decent response new covid-19 infections dropped. Odds of new SARS-CoV-2 infection were reduced 65 per cent in those who had completed 21 days since first vaccination with no second dose versus unvaccinated individuals without evidence of prior infection, the study noted. The researchers, in the large community surveillance study, conclude that vaccination with a single dose of Oxford/AstraZeneca or Pfizer/BioNTech vaccines, or two doses of Pfizer/BioNTech, significantly reduced new SARS-CoV-2 infections.

Infection Vaccine Oxford Ons Pfizer Dose 65 Finds  chances  studies  dose  uk  researchers  oxford  reduced  vaccines  infection  vaccine  vaccinated  single  covid19  study  65  finds

History of this topic

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive
5 months ago

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive

Live Mint  

New Delhi: With US President Joe Biden testing positive for COVID-19 before the Presidential elections, the World Health Organisation has warned the public that Covid is still not over. WHO director-general Tedros Adhanom Ghebreyesus issued a warning, stating that vaccination rates among health professionals and the over-60s—two demographics most at risk of dying from COVID—are alarmingly falling. Globally, 9.8 million …

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

Newest COVID shots are 54% effective in preventing symptoms, CDC finds
10 months, 3 weeks ago

Newest COVID shots are 54% effective in preventing symptoms, CDC finds

Associated Press  

NEW YORK — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work. The 54% finding is similar to what’s been reported in other countries, and it’s also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
1 year, 1 month ago

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case

The Telegraph  

As many as 80 claimants could lodge legal cases with the High Court by the end of the year in a class action that threatens to undermine faith in the rollout of the AstraZeneca vaccine that was developed jointly with Oxford University. In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of …

COVID returns? Hospitalisation hits record high in THIS country | DEETS INSIDE
1 year, 2 months ago

COVID returns? Hospitalisation hits record high in THIS country | DEETS INSIDE

India TV News  

As winter approaches, health authorities in the United Kingdom have issued a warning for its citizens to prepare for another wave of COVID-19. UK Health Security Agency has claimed that the cases will 'further increase' as the season progresses, along with other 'winter respiratory viruses like flu'. As we enter the colder months and people begin to mix more indoors, …

New COVID-19 vaccinations are coming, CDC says. The shots will likely be available this week
1 year, 3 months ago

New COVID-19 vaccinations are coming, CDC says. The shots will likely be available this week

LA Times  

Allan Fernandez, 7, middle, is vaccinated by Dr. David Bolour, left, as CDC Director Dr. Rochelle Walensky looks on in Ted Watkins Memorial Park last year. “Although hospitalization rates are currently low in some age groups, we have seen rates increase in recent weeks, and anticipate further increases as we enter respiratory virus season.” CDC Director Dr. Mandy Cohen on …

At least single dose vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality: ICMR study
1 year, 4 months ago

At least single dose vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality: ICMR study

The Hindu  

At least one dose of vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality, an Indian Council of Medical Research study on factors related to mortality within one year after discharge in hospitalised COVID-19 patients has found. Overall, the study’s findings suggest that a post-discharge mortality rate of 6.5% in patients hospitalised for COVID-19 warrants a vigilant follow-up. …

Pre-Covid shots provided 60% protection against post-infection deaths: Study
1 year, 4 months ago

Pre-Covid shots provided 60% protection against post-infection deaths: Study

India Today  

The Indian Council of Medical Research, which studied the cause of death in people after recovering from Covid-19 infection, found that those who were vaccinated before contracting the virus had 60 per cent protection against post-discharge mortality. An expert team working at the National Clinical Registry for Covid evaluated factors related to post-discharge mortality during the first year after Covid, …

COVID fourth dose might not work if…, expert on how to tackle new variant surge
1 year, 8 months ago

COVID fourth dose might not work if…, expert on how to tackle new variant surge

Live Mint  

The COVID-19 pandemic has brought about many challenges, one of which is the emergence of new variants of the virus that can evade immunity conferred by existing vaccines. While booster doses can still reduce the severity of the disease, experts are of the opinion that it may be time for governments to start thinking about second-generation vaccines. And, one of …

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims
1 year, 11 months ago

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims

India TV News  

A US-based researcher has claimed that the messenger RNA Covid-19 vaccine can increase serious adverse events in people, including sudden cardiac deaths. Joseph Fraiman, the lead author of the peer-reviewed research that re-analysed Pfizer & Moderna trials for mRNA Covid-19 vaccine, has tweeted: "I believe the mRNA Covid-19 vaccines need to be withdrawn". In another tweet, he mentioned that the …

No second Covid-19 booster dose required: Report
1 year, 11 months ago

No second Covid-19 booster dose required: Report

Live Mint  

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

COVID-19 vaccines offer significant protection against reinfection: Study
2 years, 1 month ago

COVID-19 vaccines offer significant protection against reinfection: Study

India TV News  

COVID-19 vaccine: A recent study revealed that people earlier infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60% to 94% protection against reinfection. “In our study, we find a significant vaccine effectiveness against SARS-CoV-2 reinfection, and this shows the importance of vaccination also for those who might be protected by natural immunity," said Katrine Finderup Nielsen …

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity
2 years, 1 month ago

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity

The Independent  

Cancer drugs worked better after patients had had Covid-19 jabs, scientists have discovered. Patients with nasopharyngeal cancer – in the area from the back of the nose to the upper part of the throat – who had had a coronavirus vaccine “responded significantly better” to treatment than unvaccinated patients, according to German and Chinese experts. They were surprised when the …

Repeat covid vaccinations opened to all as postive tests mount
2 years, 2 months ago

Repeat covid vaccinations opened to all as postive tests mount

Dutch News  

Everyone over the age of 12 is now being invited to sign up for another coronavirus vaccination, the health ministry has confirmed. With covid infections once again on the rise, health officials say getting the top-up jabs will help slow the spread of the virus. People aged 40 to 60 can make an appointment via website planjeprik.nl next week, while …

Repeat covid vaccinations opened to all as postive tests mount
2 years, 2 months ago

Repeat covid vaccinations opened to all as postive tests mount

Dutch News  

Everyone over the age of 12 is now being invited to sign up for another coronavirus vaccination, the health ministry has confirmed. With covid infections once again on the rise, health officials say getting the top-up jabs will help slow the spread of the virus. People aged 40 to 60 can make an appointment via website planjeprik.nl next week, while …

4 Cr Eligible Beneficiaries Havn't Taken Even Single Dose of Covid-19 Vaccine as on July 18: Govt
2 years, 5 months ago

4 Cr Eligible Beneficiaries Havn't Taken Even Single Dose of Covid-19 Vaccine as on July 18: Govt

News 18  

An estimated 4 crore eligible beneficiaries have not taken even a single dose of COVID-19 vaccine as on July 18, Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday. A total of 1,78,38,52,566 vaccine doses have been administered free of cost in Government Covid Vaccination Centres till July 18, she said in a written reply. …

Covid cases jump by 800,000 in a week
2 years, 5 months ago

Covid cases jump by 800,000 in a week

The Telegraph  

Covid-19 infections in the UK have jumped by nearly 800,000 in a week, with some parts of the country nearing the record levels seen during the spring. This is the highest estimate for total infections since mid-April, but is still below the record of 4.9 million seen at the peak of the omicron BA.2 wave at the end of March. …

Covid vaccine effectiveness falls to 0% a year after first series
2 years, 5 months ago

Covid vaccine effectiveness falls to 0% a year after first series

NL Times  

People who have only received the first and second vaccine shots against Covid-19 are barely protected against a coronavirus infection one year after the injections. By that time, vaccine effectiveness falls to 0 percent, according to the RIVM, the Dutch public health institute. Those who received a booster shot in the interim still receive protection against serious symptoms of the …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

FDA advisors back Novavax COVID-19 vaccine as a new U.S. option
2 years, 6 months ago

FDA advisors back Novavax COVID-19 vaccine as a new U.S. option

LA Times  

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisors to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional tech- nology than today’s U.S. options. …

Covid Vaccine Immunity Wanes Faster in Cancer Patients, Boosters Are Best Shot: UK Study
2 years, 7 months ago

Covid Vaccine Immunity Wanes Faster in Cancer Patients, Boosters Are Best Shot: UK Study

News 18  

Some cancer patients are showing a rapid decline in Covid-19 vaccine effectiveness by three to six months compared to the general population, says a large-scale study carried out by the UK Coronavirus Cancer Evaluation Project, stressing on the importance of booster doses for those battling the malignant disease. They also found that vaccines offered higher protection against Covid-associated hospitalisation than …

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study
2 years, 7 months ago

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study

India TV News  

A fourth dose of the Pfizer or Moderna COVID-19 vaccine is safe and boosts antibody levels, even higher than that of a third dose, according to the latest results from a nationwide study in the UK. The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received …

New oral Covid vaccine can decrease severity, transmission: Study
2 years, 7 months ago

New oral Covid vaccine can decrease severity, transmission: Study

India Today  

An investigational Covid vaccine designed to be administered orally has not only limited the degree of the disease but also decreased its airborne spread during its trial on animals, revealed a study published in the journal, Science Translational Medicine, earlier this week. The research team led by Duke University researcher Stephanie N Langel, a medical instructor in the Department of …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 7 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

UK clears 6th Covid vaccine despite cancelling deal for doses
2 years, 8 months ago

UK clears 6th Covid vaccine despite cancelling deal for doses

India Today  

British authorities have authorized a coronavirus vaccine for adults made by French drugmaker Valneva, despite the government's decision last year to cancel an order for at least 100 million doses. Britain's medicines regulator said Thursday that the two-dose vaccine is intended for adults ages 18 to 50, with the second dose given about a month after the first. FULL CORONAVIRUS …

In First Quantitative Sero-survey in Mumbai, 99.93% Participants Found with Covid-19 Antibodies
2 years, 8 months ago

In First Quantitative Sero-survey in Mumbai, 99.93% Participants Found with Covid-19 Antibodies

News 18  

In the first quantitative sero-survey conducted in March this year, COVID-19 antibodies were found in 3,097 out of the 3,099 health and frontline workers, who were examined, the Brihanmumbai Municipal Corporation said. Comparatively, more antibodies were found in the blood samples of the employees, who have taken the preventive or booster doses of COVID-19 vaccines as compared to the fully …

India approves ‘precaution’ doses of COVID-19 vaccine for all over 18 from April 10
2 years, 8 months ago

India approves ‘precaution’ doses of COVID-19 vaccine for all over 18 from April 10

The Hindu  

The Union Health Ministry on Friday announced that the precautionary or third dose of COVID-19 vaccine would be made available to the 18+ population at private vaccination centres. 1,109 new infections The decision comes even as India logged 1,109 new coronavirus infections taking the total tally of COVID-19 cases to 4,30,33,067,while the active cases dipped to 11,492, according to the …

Breaking News, March 25
2 years, 9 months ago

Breaking News, March 25

India TV News  

Against the estimated population of 101.3 crore beneficiaries aged 15 years and above, a total of 181.24 crore doses of COVID-19 vaccines were administered in the country as on March 21, the government informed Parliament on Friday. In a written reply to a question in the Lok Sabha, Union Health Minister Mansukh Mandaviya said a total of 9.71 crore first …

Better to err on the side of caution to ensure public health during pandemic, TN tells SC
2 years, 9 months ago

Better to err on the side of caution to ensure public health during pandemic, TN tells SC

The Hindu  

States like Tamil Nadu and Maharashtra in the Supreme Court on Tuesday justified their hardened stand to make COVID-19 inoculation mandatory, even at the cost of denying people their rights, by saying that it was better to err on the side of caution to prevent serious or irreversible harm to the public when there was insufficient information about the virus. …

COVID-19: Over 3 lakh doses of Corbevax vaccine given to children aged 12-14 years on day 1
2 years, 9 months ago

COVID-19: Over 3 lakh doses of Corbevax vaccine given to children aged 12-14 years on day 1

Firstpost  

The vaccination against COVID-19 in this age group started on Wednesday with Biological E’s intramuscular vaccine, two doses of which are to be administered 28 days apart New Delhi: Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the country to over 180.80 crore, according to …

Second COVID booster shot does little to stop Omicron, study finds
2 years, 9 months ago

Second COVID booster shot does little to stop Omicron, study finds

LA Times  

Dr. Jacov Lavee receives a fourth dose of the Comirnaty vaccine in Ramat Gan, Israel, as part of a trial to test whether a second COVID-19 booster shot helps protect against infection and illness. Compared to getting two initial doses and one booster shot of Pfizer and BioNTech’s Comirnaty vaccine, adding a second booster shot reduced the rate of coronavirus …

Coronavirus updates March 04, 2022
2 years, 9 months ago

Coronavirus updates March 04, 2022

The Hindu  

In 2022, 92% of COVID deaths have been in unvaccinated individuals, Director General of the Indian Council of Medical Research Dr. Balram Bhargava said on Thursday. Here are the latest updates Study Third Covid vaccine dose advised for immunocompromised people: study A third dose of the COVID-19 vaccine is recommended for people with a weakened immune system, especially for organ …

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
2 years, 9 months ago

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients

Daily Mail  

The Johnson & Johnson COVID-19 vaccine was not nearly as effective as its peers at preventing hospitalization from the virus, a new study of elderly patients finds. A French research team found that 28 days after administration of the single-dose J&J shot, and the second dose of the Pfizer-BioNTech vaccine, the J&J recipients were 5.2 times more likely to be …

Pfizer vaccine less effective against Covid19 in kids aged 5-11: Study
2 years, 9 months ago

Pfizer vaccine less effective against Covid19 in kids aged 5-11: Study

India TV News  

Highlights The effectiveness of the Pfizer vaccine for children waned quickly during the Omicron surge in US Effectiveness against hospitalisation in children from age 5 to 11 dropped substantially dropped Vaccine effectiveness fell more slowly for smaller children as it did for older children The effectiveness of the Pfizer COVID-19 vaccine for children waned quickly during the Omicron surge in …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
2 years, 10 months ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

Three doses of Pfizer Covid vaccine better than two: Study
2 years, 10 months ago

Three doses of Pfizer Covid vaccine better than two: Study

Deccan Chronicle  

Washington: A third dose of the Pfizer COVID-19 vaccine conferred higher effectiveness against infection and hospitalisation than two doses of the preventive after one month, a study has found. "When we looked at the effectiveness of the two doses of Pfizer–BioNTech vaccine versus three doses, we see a benefit with three doses that exceeds that achieved with two doses alone," …

Vaccine protection better maintained against severe COVID-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe COVID-19: Lancet study

Firstpost  

The results showed that protection against infection of any severity waned progressively following the peak which occurred a month after the second dose London: The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. “The bad news is that the …

Vaccine protection better maintained against severe Covid-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe Covid-19: Lancet study

India Today  

The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. "The bad news is that the protection against infection seems to be diminished by seven months after the second dose of vaccine," said Peter Nordstrom, a professor at Umea University …

Vaccine protection better maintained against severe COVID-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe COVID-19: Lancet study

Deccan Chronicle  

London: The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. "The bad news is that the protection against infection seems to be diminished by seven months after the second dose of vaccine," said Peter Nordstrom, a professor at Umea …

Less than one in three young adults in big cities have had booster
2 years, 10 months ago

Less than one in three young adults in big cities have had booster

The Independent  

Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Less than a third of young adults in many of …

Can vaccination reduce long effects of Covid-19? Here's what we know
2 years, 10 months ago

Can vaccination reduce long effects of Covid-19? Here's what we know

Hindustan Times  

Vaccination can help reduce the long effects of Covid-19 infection, researchers have found based on data collected from those infected with coronavirus. An Israeli report has surfaced that shows that people vaccinated with both doses of the Pfizer-BioNTech vaccine were much less likely to report long Covid as compared to those unvaccinated. The term ‘long Covid’ refers to a condition …

COVID-19 vaccination, including booster shots, to be delayed by 3 months post-recovery: Centre
2 years, 11 months ago

COVID-19 vaccination, including booster shots, to be delayed by 3 months post-recovery: Centre

Firstpost  

India has so far administered more than 161 crore vaccine doses including 74 lakh precaution jabs, says government The Union Health Ministry has issued new guidelines stating that if any beneficiary tests COVID-19 positive, then all vaccination plus precaution dose must be delayed by three months after recovery. “In case of individuals having lab test proven SARS-2 Covid-19 illness, all …

COVID19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID19 vaccines offer lasting protection, claims study

India TV News  

New research has found that COVID vaccination offers long-lasting protection from the worst outcomes of infection. The study found that the effectiveness of the Pfizer and Moderna mRNA vaccines in reducing the risk of COVID-19 reached a peak of about 95 per cent two months after the first dose and then gradually declined. At seven months, the Pfizer vaccine dropped …

COVID-19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID-19 vaccines offer lasting protection, claims study

India TV News  

A new research has found that COVID-19 vaccination offers long-lasting protection from the worst outcomes of COVID-19. "This is an excellent example of the wonderful research partnership between the Gillings School and NCDHHS, who are working together to generate the evidence base needed to keep our communities safe," said Penny Gordon-Larsen, PhD, Carla Smith Chamblee Distinguished Professor of Global Nutrition …

2 Vaccine Doses, Previous Infection May Protect Against Covid for a Year: Study
2 years, 11 months ago

2 Vaccine Doses, Previous Infection May Protect Against Covid for a Year: Study

News 18  

Many wonder how much of an impact the vaccine has had on the Covid-19. According to new research, a person who has previously had Covid and has had two doses of the vaccine, will have 90 percent protection against the virus for an additional year. According to the research, the best strategy to guard against future Covid infection is to …

Fourth shot of Covid vaccine is NOT enough to prevent 'lots of infections' from Omicron
2 years, 11 months ago

Fourth shot of Covid vaccine is NOT enough to prevent 'lots of infections' from Omicron

Daily Mail  

Even a fourth dose of a Covid vaccine isn't enough to stop people getting infected with Omicron, according to the preliminary results of a trial. The fourth dose of the Covid vaccine is less effective on the Omicron variant and provides only limited defence, a preliminary study in Israel has found Israel was the first country in the world to …

Why Corbevax, Covovax haven't made the cut for the third dose yet?
2 years, 11 months ago

Why Corbevax, Covovax haven't made the cut for the third dose yet?

India Today  

As the third wave of Covid sweeps over India, the debate of the need for a booster dose rages on. The World Health Organization’s Technical Advisory Group on Covid-19 vaccine composition, in its interim statement on Covid-19 vaccine in the context of the circulation of the Omicron Variant, said: “A vaccination strategy based on repeated booster doses of the original …

Poorer nations reject over 100 million Covid shots as many close to expiry
2 years, 11 months ago

Poorer nations reject over 100 million Covid shots as many close to expiry

India Today  

Poorer nations last month rejected more than 100 million doses of Covid-19 vaccines distributed by the global programme COVAX, mainly due to their rapid expiry date, a UNICEF official said on Thursday. UNICEF's data on supplies and use of delivered vaccines show that 681 million shipped doses are currently stored in about 90 poorer nations, according to CARE, a charity, …

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment
2 years, 11 months ago

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment

News 18  

The UK's health service on Tuesday marked the first anniversary of the deployment of the Oxford/AstraZeneca vaccine against COVID-19, manufactured and deployed in India soon after as Covishield. "Backed by government funding, the UK-made Oxford-AstraZeneca vaccine has played an absolutely crucial role in our fight against COVID-19, saving countless lives in the UK and around the world," said UK Health …

Discover Related